Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

Curr Neuropharmacol. 2021;19(6):885-895. doi: 10.2174/1570159X18666200924122732.

Abstract

It is a known fact that inflammation affects several physiological processes, including the functioning of the central nervous system. Additionally, impairment of lipid mechanisms/pathways have been associated with a number of neurodegenerative disorders and Alzheimer's Disease (AD) is one of them. However, much attention has been given to the link between tau and beta- amyloid hypothesis in AD pathogenesis/prognosis. Increasing evidences suggest that biologically active lipid molecules could influence the pathophysiology of AD via a different mechanism of inflammation. This review intends to highlight the role of inflammatory responses in the context of AD with the emphasis on biochemical pathways of lipid metabolism enzyme, 5-lipoxygenase (5- LO).

Keywords: 5-lipoxygenase; Alzheimer's Diseases; Arachidonic Acid.; Lipid Molecule; Neuro Inflammation; Neurodegeneration.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Arachidonate 5-Lipoxygenase*
  • Humans
  • Inflammation

Substances

  • Amyloid beta-Peptides
  • Arachidonate 5-Lipoxygenase